Infliximab, azathioprine, or combination therapy for Crohn's disease.
| Publicado en: | New England Journal of Medicine Vol. 363; no. 11; pp. 1086 - 1089 |
|---|---|
| Autores principales: | , |
| Formato: | commentary letter response Journal Article |
| Publicado: |
New England Journal of Medicine
9/9/2010
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105107698&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 105107698 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00284793 NEJ jtl: New England Journal of Medicine issn: 00284793 maglogo: N pubinfo: dt: 9/9/2010 vid: 363 iid: 11 pid: 388 pub: New England Journal of Medicine place: Waltham, Massachusetts artinfo: ui: 105107698 105107698 NLM20848680 2010797164 10.1056/NEJMc1005805 NLM20848680 105107698 ppf: 1086 ppct: 3 formats: tig: atl: Infliximab, azathioprine, or combination therapy for Crohn's disease. aug: au: Gelber AC Gelber, Allan C sug: subj: Antibodies, Monoclonal Therapeutic Use Azathioprine Therapeutic Use Crohn Disease Drug Therapy Immunosuppressive Agents Therapeutic Use Antiinflammatory Agents Therapeutic Use Arthritis Complications Arthritis Drug Therapy Drug Therapy, Combination Pyoderma Gangrenosum Complications Pyoderma Gangrenosum Drug Therapy pubtype: Academic Journal doctype: commentary letter response Journal Article ougenre: Unknown ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|